Quantitative Investment Management LLC Makes New $988,000 Investment in Cigna Group $CI

Quantitative Investment Management LLC bought a new stake in Cigna Group (NYSE:CI) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 3,586 shares of the health services provider’s stock, valued at approximately $988,000.

Several other hedge funds and other institutional investors have also modified their holdings of the business. Brighton Jones LLC grew its holdings in shares of Cigna Group by 9.3% during the fourth quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider’s stock valued at $1,032,000 after buying an additional 318 shares in the last quarter. Sivia Capital Partners LLC lifted its stake in Cigna Group by 10.4% in the 2nd quarter. Sivia Capital Partners LLC now owns 1,160 shares of the health services provider’s stock worth $384,000 after acquiring an additional 109 shares in the last quarter. NewEdge Advisors LLC boosted its position in Cigna Group by 4.5% during the 2nd quarter. NewEdge Advisors LLC now owns 22,225 shares of the health services provider’s stock worth $7,347,000 after acquiring an additional 958 shares during the period. Treasurer of the State of North Carolina grew its stake in Cigna Group by 16.6% during the 2nd quarter. Treasurer of the State of North Carolina now owns 148,840 shares of the health services provider’s stock valued at $49,204,000 after acquiring an additional 21,173 shares in the last quarter. Finally, Osterweis Capital Management Inc. purchased a new position in Cigna Group during the 2nd quarter valued at about $163,000. Institutional investors and hedge funds own 86.99% of the company’s stock.

Insider Buying and Selling at Cigna Group

In other news, insider Nicole S. Jones sold 19,436 shares of the company’s stock in a transaction dated Tuesday, August 4th. The stock was sold at an average price of $276.27, for a total transaction of $5,369,583.72. Following the completion of the sale, the insider owned 27,256 shares in the company, valued at approximately $7,530,015.12. This represents a 41.63% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $298.61, for a total value of $268,450.39. Following the transaction, the chief accounting officer directly owned 2,368 shares in the company, valued at approximately $707,108.48. This represents a 27.52% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 23,012 shares of company stock worth $6,386,550 over the last three months. Company insiders own 0.60% of the company’s stock.

Analyst Upgrades and Downgrades

CI has been the subject of a number of research analyst reports. Deutsche Bank Aktiengesellschaft lowered shares of Cigna Group from a “buy” rating to a “hold” rating and reduced their price target for the stock from $303.00 to $302.00 in a research report on Wednesday, May 20th. Jefferies Financial Group lowered shares of Cigna Group from a “buy” rating to a “hold” rating and dropped their price objective for the company from $336.00 to $307.00 in a research note on Tuesday, August 4th. Barclays lifted their target price on shares of Cigna Group from $304.00 to $310.00 and gave the company an “equal weight” rating in a research note on Friday, July 31st. Wells Fargo & Company boosted their price target on shares of Cigna Group from $305.00 to $307.00 and gave the company an “equal weight” rating in a report on Friday, July 31st. Finally, Piper Sandler dropped their price target on shares of Cigna Group from $370.00 to $346.00 and set an “overweight” rating on the stock in a research note on Wednesday, June 3rd. Fifteen equities research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $339.45.

Cigna Group Price Performance

Shares of CI opened at $282.90 on Wednesday. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.76 and a current ratio of 0.76. The firm has a market cap of $74.75 billion, a PE ratio of 11.70, a PEG ratio of 0.95 and a beta of 0.31. The firm’s 50 day moving average price is $283.40 and its 200 day moving average price is $281.14. Cigna Group has a twelve month low of $239.51 and a twelve month high of $315.47.

Cigna Group (NYSE:CI) last posted its earnings results on Thursday, July 30th. The health services provider reported $7.78 EPS for the quarter, topping the consensus estimate of $7.60 by $0.18. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The company had revenue of $70.04 billion during the quarter, compared to the consensus estimate of $70.14 billion. During the same period in the previous year, the firm posted $7.20 earnings per share. The company’s revenue for the quarter was up 6.7% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.450- EPS. As a group, research analysts expect that Cigna Group will post 30.51 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 23rd. Shareholders of record on Tuesday, September 8th will be given a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a yield of 2.2%. The ex-dividend date of this dividend is Tuesday, September 8th. Cigna Group’s dividend payout ratio is presently 25.82%.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.